After AbbVie, Teva walks away from influential trade group PhRMA

Taking a cue from AbbVie’s playbook, Teva is the latest drugmaker to walk away from the Pharmaceutical Research and Manufacturers of America (PhRMA).

“Teva has decided not to renew its membership with PhRMA in 2023,” Brian Newell, spokesperson for the influential lobbying group, said over email. Teva also confirmed its departure in a statement provided to Fierce Pharma.